Research institute
Preclinical research finds new approach to treating aggressive cancer unresponsive to immunotherapy alone
Directly activating a gene important to exciting our excitatory neurons and associated with major depression may help turn around classic symptoms like social isolation and loss of interest, at least for males, scientists report.
Could a drug used to treat tapeworms be effective at treating a type of cancer? Researchers in Singapore think they are on the right track in demonstrating just that.
Singapore clinicians and scientists have discovered an unprecedented use of an FDA-approved drug to kill p53-defective cancer cells
Two checkpoint inhibitors provide early encouraging results for immunologically cold disease
Preclinical study identifies vulnerability in orphan cancers with SMARCB1 mutations, spurs launch of Phase II clinical trial
Mimicking how the biological world arranges itself could help advance the next generation of nanomaterials.
There are plenty of great scientific research stories out this week. Here’s a look at just a few of them.
Although bioterrorism doesn’t get the kind of attention more traditional bombings and shootings receive, the biotech industry and the federal government are paying attention and actively funding and developing countermeasures to potential bioterror, military and public health emergencies.
There are plenty of great scientific research stories out this week. Here’s a look at just a few of them.
PRESS RELEASES